navigator tissue uk limited
navigator tissue uk limited Company Information
Company Number
03639930
Next Accounts
Jan 2026
Shareholders
accrol holdings limited
Group Structure
View All
Industry
Manufacture of household and sanitary goods and of toilet requisites
+1Registered Address
delta building roman road, blackburn, BB1 2LD
Website
www.accrol.co.uknavigator tissue uk limited Estimated Valuation
Pomanda estimates the enterprise value of NAVIGATOR TISSUE UK LIMITED at £159m based on a Turnover of £186.8m and 0.85x industry multiple (adjusted for size and gross margin).
navigator tissue uk limited Estimated Valuation
Pomanda estimates the enterprise value of NAVIGATOR TISSUE UK LIMITED at £99.3m based on an EBITDA of £13.6m and a 7.28x industry multiple (adjusted for size and gross margin).
navigator tissue uk limited Estimated Valuation
Pomanda estimates the enterprise value of NAVIGATOR TISSUE UK LIMITED at £12.8m based on Net Assets of £8.5m and 1.5x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Navigator Tissue Uk Limited Overview
Navigator Tissue Uk Limited is a live company located in blackburn, BB1 2LD with a Companies House number of 03639930. It operates in the manufacture of paper and paperboard sector, SIC Code 17120. Founded in September 1998, it's largest shareholder is accrol holdings limited with a 100% stake. Navigator Tissue Uk Limited is a mature, mega sized company, Pomanda has estimated its turnover at £186.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Navigator Tissue Uk Limited Health Check
Pomanda's financial health check has awarded Navigator Tissue Uk Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
3 Weak
Size
annual sales of £186.8m, make it larger than the average company (£23.1m)
£186.8m - Navigator Tissue Uk Limited
£23.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (11.1%)
14% - Navigator Tissue Uk Limited
11.1% - Industry AVG
Production
with a gross margin of 26.9%, this company has a lower cost of product (21.7%)
26.9% - Navigator Tissue Uk Limited
21.7% - Industry AVG
Profitability
an operating margin of 2.9% make it less profitable than the average company (4.2%)
2.9% - Navigator Tissue Uk Limited
4.2% - Industry AVG
Employees
with 396 employees, this is above the industry average (92)
396 - Navigator Tissue Uk Limited
92 - Industry AVG
Pay Structure
on an average salary of £55k, the company has an equivalent pay structure (£49.1k)
£55k - Navigator Tissue Uk Limited
£49.1k - Industry AVG
Efficiency
resulting in sales per employee of £471.7k, this is more efficient (£312.4k)
£471.7k - Navigator Tissue Uk Limited
£312.4k - Industry AVG
Debtor Days
it gets paid by customers after 34 days, this is earlier than average (49 days)
34 days - Navigator Tissue Uk Limited
49 days - Industry AVG
Creditor Days
its suppliers are paid after 104 days, this is slower than average (51 days)
104 days - Navigator Tissue Uk Limited
51 days - Industry AVG
Stock Days
it holds stock equivalent to 51 days, this is in line with average (44 days)
51 days - Navigator Tissue Uk Limited
44 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (2 weeks)
1 weeks - Navigator Tissue Uk Limited
2 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.1%, this is a higher level of debt than the average (52.2%)
94.1% - Navigator Tissue Uk Limited
52.2% - Industry AVG
NAVIGATOR TISSUE UK LIMITED financials
Navigator Tissue Uk Limited's latest turnover from April 2024 is £186.8 million and the company has net assets of £8.5 million. According to their latest financial statements, Navigator Tissue Uk Limited has 396 employees and maintains cash reserves of £2.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 186,791,000 | 264,488,000 | 145,429,000 | 124,599,000 | 134,773,000 | 119,111,000 | 139,738,000 | 134,163,000 | 118,219,000 | 101,056,000 | 87,662,000 | 74,832,000 | 63,489,000 | 50,045,136 | 38,171,686 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 136,596,000 | 227,459,000 | 122,569,000 | 92,474,000 | 105,239,000 | 101,559,000 | 115,232,000 | 96,766,000 | 83,730,000 | 75,850,000 | 63,696,000 | 52,778,000 | 45,726,000 | 38,324,478 | 27,942,668 |
| Gross Profit | 50,195,000 | 37,029,000 | 22,860,000 | 32,125,000 | 29,534,000 | 17,552,000 | 24,506,000 | 37,397,000 | 34,489,000 | 25,206,000 | 23,966,000 | 22,054,000 | 17,763,000 | 11,720,658 | 10,229,018 |
| Admin Expenses | 44,687,000 | 33,366,000 | 29,819,000 | 31,181,000 | 27,627,000 | 28,109,000 | 45,282,000 | 24,830,000 | 20,096,000 | 15,406,000 | 15,742,000 | 13,553,000 | 9,811,000 | 6,380,923 | 5,495,805 |
| Operating Profit | 5,508,000 | 3,663,000 | -6,959,000 | 944,000 | 1,907,000 | -10,557,000 | -20,776,000 | 12,567,000 | 14,393,000 | 9,800,000 | 8,224,000 | 8,501,000 | 7,952,000 | 5,339,735 | 4,733,213 |
| Interest Payable | 3,895,000 | 8,988,000 | 1,271,000 | 959,000 | 1,230,000 | 564,000 | 318,000 | 241,000 | 541,000 | 548,000 | 613,000 | 430,000 | 343,000 | 205,073 | 185,725 |
| Interest Receivable | 336,000 | 265,000 | 216,000 | 242,000 | 267,000 | 132 | |||||||||
| Pre-Tax Profit | 1,949,000 | -5,060,000 | -8,014,000 | 227,000 | 944,000 | -11,121,000 | -21,094,000 | 12,326,000 | 13,852,000 | 9,252,000 | 7,611,000 | 8,071,000 | 7,609,000 | 5,134,794 | 4,547,488 |
| Tax | 513,000 | 1,190,000 | 1,488,000 | -304,000 | 97,000 | 1,761,000 | 3,702,000 | -2,227,000 | -1,979,000 | -1,664,000 | -1,589,000 | -1,896,000 | -1,851,000 | -1,383,018 | -1,301,655 |
| Profit After Tax | 2,462,000 | -3,870,000 | -6,526,000 | -77,000 | 1,041,000 | -9,360,000 | -17,392,000 | 10,099,000 | 11,873,000 | 7,588,000 | 6,022,000 | 6,175,000 | 5,758,000 | 3,751,776 | 3,245,833 |
| Dividends Paid | 910,000 | 1,500,000 | 3,600,000 | 2,196,000 | 2,245,000 | ||||||||||
| Retained Profit | 2,462,000 | -3,870,000 | -6,526,000 | -77,000 | 1,041,000 | -9,360,000 | -17,392,000 | 10,099,000 | 11,873,000 | 6,678,000 | 6,022,000 | 4,675,000 | 2,158,000 | 1,555,776 | 1,000,833 |
| Employee Costs | 21,783,000 | 15,382,000 | 13,385,000 | 17,788,000 | 15,952,000 | 14,000,000 | 14,302,000 | 11,661,000 | 9,927,000 | 7,108,000 | 4,973,000 | 4,630,000 | 3,689,000 | 2,475,295 | 2,070,461 |
| Number Of Employees | 396 | 315 | 286 | 389 | 418 | 388 | 510 | 508 | 460 | 26 | 241 | 214 | 149 | 103 | 77 |
| EBITDA* | 13,649,000 | 7,706,000 | -2,702,000 | 5,082,000 | 6,090,000 | -8,087,000 | -18,221,000 | 12,567,000 | 16,224,000 | 11,540,000 | 9,313,000 | 9,394,000 | 8,663,000 | 5,741,598 | 5,134,783 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 49,171,000 | 83,968,000 | 68,661,000 | 54,991,000 | 48,981,000 | 30,915,000 | 24,623,000 | 27,341,000 | 24,271,000 | 22,586,000 | 15,880,000 | 10,529,000 | 10,752,000 | 7,457,706 | 5,180,754 |
| Intangible Assets | 39,634,000 | 5,304,000 | 5,545,000 | 3,345,000 | 3,256,000 | ||||||||||
| Investments & Other | 4,023,000 | ||||||||||||||
| Debtors (Due After 1 year) | 2,347,000 | 8,671,000 | 8,074,000 | 7,542,000 | 7,504,000 | ||||||||||
| Total Fixed Assets | 95,175,000 | 84,218,000 | 70,457,000 | 55,821,000 | 50,436,000 | 30,915,000 | 24,623,000 | 27,341,000 | 24,271,000 | 22,586,000 | 15,880,000 | 10,529,000 | 10,752,000 | 7,457,706 | 5,180,754 |
| Stock & work in progress | 19,203,000 | 22,927,000 | 19,907,000 | 16,867,000 | 9,373,000 | 11,162,000 | 14,057,000 | 14,981,000 | 9,361,000 | 9,381,000 | 9,124,000 | 7,943,000 | 7,992,000 | 3,109,983 | 2,929,130 |
| Trade Debtors | 17,552,000 | 23,970,000 | 20,814,000 | 14,824,000 | 16,909,000 | 20,981,000 | 27,845,000 | 22,690,000 | 20,708,000 | 19,144,000 | 16,759,000 | 14,442,000 | 12,991,000 | 9,127,134 | 7,301,150 |
| Group Debtors | 4,346,000 | 6,931,000 | 1,032,000 | 4,500,000 | 1,500,000 | ||||||||||
| Misc Debtors | 6,448,000 | 3,602,000 | 4,211,000 | 2,672,000 | 3,771,000 | 2,064,000 | 2,019,000 | 1,006,000 | 523,000 | 154,000 | 940,000 | 1,614,000 | 573,000 | 717,072 | 478,250 |
| Cash | 2,339,000 | 3,393,000 | 62,000 | 5,850,000 | 8,147,000 | 2,166,000 | 134,000 | 3,554,000 | 2,135,000 | 675,000 | 12,000 | 542,000 | 11,000 | 4,901 | 30,403 |
| misc current assets | 1,097,000 | 1,508,000 | 675,000 | 677,000 | 241,000 | 2,198,000 | 841,000 | ||||||||
| total current assets | 49,888,000 | 54,989,000 | 46,502,000 | 40,888,000 | 38,917,000 | 36,614,000 | 46,253,000 | 43,072,000 | 39,658,000 | 30,386,000 | 31,335,000 | 26,041,000 | 21,567,000 | 12,959,090 | 10,738,933 |
| total assets | 145,063,000 | 139,207,000 | 116,959,000 | 96,709,000 | 89,353,000 | 67,529,000 | 70,876,000 | 70,413,000 | 63,929,000 | 52,972,000 | 47,215,000 | 36,570,000 | 32,319,000 | 20,416,796 | 15,919,687 |
| Bank overdraft | 295,000 | 327,000 | 318,116 | 2,056,021 | |||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 39,210,000 | 43,337,000 | 33,343,000 | 24,091,000 | 17,099,000 | 11,107,000 | 8,859,000 | 15,156,000 | 7,726,000 | 9,491,000 | 7,123,000 | 8,156,000 | 9,046,000 | 6,415,205 | 5,591,922 |
| Group/Directors Accounts | 43,469,000 | 5,000 | 28,000 | 370,000 | 4,921 | ||||||||||
| other short term finances | 16,000 | 20,483,000 | 15,630,000 | 120,000 | 11,817,000 | 13,690,000 | 18,677,000 | 9,523,000 | 7,485,000 | 5,829,000 | |||||
| hp & lease commitments | 6,434,000 | 7,333,000 | 3,235,000 | 8,837,000 | 4,704,000 | 1,383,000 | 223,000 | 186,000 | 3,605,000 | 5,566,000 | 2,134,000 | 1,375,000 | 1,357,000 | 899,058 | 681,132 |
| other current liabilities | 15,101,000 | 36,474,000 | 35,410,000 | 40,561,000 | 32,750,000 | 31,544,000 | 26,432,000 | 14,311,000 | 4,397,000 | 5,167,000 | 14,067,000 | 11,925,000 | 9,731,000 | 4,596,396 | 2,064,722 |
| total current liabilities | 104,230,000 | 107,627,000 | 87,618,000 | 73,609,000 | 66,370,000 | 57,724,000 | 54,191,000 | 39,176,000 | 23,213,000 | 26,053,000 | 23,624,000 | 21,484,000 | 20,831,000 | 12,233,696 | 10,393,797 |
| loans | 58,664,000 | 47,364,000 | 22,510,000 | 27,720,000 | 4,472,000 | 608,000 | 1,210,000 | 14,464,000 | 10,888,000 | ||||||
| hp & lease commitments | 32,296,000 | 29,332,000 | 23,682,000 | 11,255,000 | 13,860,000 | 2,236,000 | 304,000 | 368,000 | 7,232,000 | 5,444,000 | 5,221,000 | 2,789,000 | 3,958,000 | 2,984,053 | 2,031,478 |
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 766,000 | 4,280,000 | 5,574,000 | 3,464,000 | 3,142,000 | 2,746,000 | 1,124,000 | 1,073,000 | 981,000 | 808,024 | 659,165 | ||||
| total long term liabilities | 32,296,000 | 29,332,000 | 23,682,000 | 11,255,000 | 14,243,000 | 4,376,000 | 3,091,000 | 2,574,000 | 8,803,000 | 6,817,000 | 6,345,000 | 3,862,000 | 4,939,000 | 3,792,077 | 2,690,643 |
| total liabilities | 136,526,000 | 136,959,000 | 111,300,000 | 84,864,000 | 80,613,000 | 62,100,000 | 57,282,000 | 41,750,000 | 32,016,000 | 32,870,000 | 29,969,000 | 25,346,000 | 25,770,000 | 16,025,773 | 13,084,440 |
| net assets | 8,537,000 | 2,248,000 | 5,659,000 | 11,845,000 | 8,740,000 | 5,429,000 | 13,594,000 | 28,663,000 | 31,913,000 | 20,102,000 | 17,246,000 | 11,224,000 | 6,549,000 | 4,391,023 | 2,835,247 |
| total shareholders funds | 8,537,000 | 2,248,000 | 5,659,000 | 11,845,000 | 8,740,000 | 5,429,000 | 13,594,000 | 28,663,000 | 31,913,000 | 20,102,000 | 17,246,000 | 11,224,000 | 6,549,000 | 4,391,023 | 2,835,247 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 5,508,000 | 3,663,000 | -6,959,000 | 944,000 | 1,907,000 | -10,557,000 | -20,776,000 | 12,567,000 | 14,393,000 | 9,800,000 | 8,224,000 | 8,501,000 | 7,952,000 | 5,339,735 | 4,733,213 |
| Depreciation | 2,128,000 | 4,043,000 | 4,257,000 | 4,138,000 | 4,183,000 | 2,470,000 | 2,555,000 | 1,831,000 | 1,740,000 | 1,089,000 | 893,000 | 711,000 | 401,863 | 401,570 | |
| Amortisation | 6,013,000 | ||||||||||||||
| Tax | 513,000 | 1,190,000 | 1,488,000 | -304,000 | 97,000 | 1,761,000 | 3,702,000 | -2,227,000 | -1,979,000 | -1,664,000 | -1,589,000 | -1,896,000 | -1,851,000 | -1,383,018 | -1,301,655 |
| Stock | -3,724,000 | 3,020,000 | 3,040,000 | 7,494,000 | -1,789,000 | -2,895,000 | -924,000 | 5,620,000 | -20,000 | 257,000 | 1,181,000 | -49,000 | 4,882,017 | 180,853 | 2,929,130 |
| Debtors | -5,550,000 | 3,144,000 | 8,061,000 | -3,146,000 | 5,139,000 | -6,819,000 | 6,168,000 | -4,466,000 | 7,832,000 | -1,869,000 | 4,643,000 | 3,992,000 | 3,719,794 | 2,064,806 | 7,779,400 |
| Creditors | -4,127,000 | 9,994,000 | 9,252,000 | 6,992,000 | 5,992,000 | 2,248,000 | -6,297,000 | 7,430,000 | -1,765,000 | 2,368,000 | -1,033,000 | -890,000 | 2,630,795 | 823,283 | 5,591,922 |
| Accruals and Deferred Income | -21,373,000 | 1,064,000 | -5,151,000 | 7,811,000 | 1,206,000 | 5,112,000 | 12,121,000 | 9,914,000 | -770,000 | -8,900,000 | 2,142,000 | 2,194,000 | 5,134,604 | 2,531,674 | 2,064,722 |
| Deferred Taxes & Provisions | -766,000 | -3,514,000 | -1,294,000 | 2,110,000 | 322,000 | 396,000 | 1,622,000 | 51,000 | 92,000 | 172,976 | 148,859 | 659,165 | |||
| Cash flow from operations | -2,064,000 | 13,790,000 | -8,214,000 | 14,467,000 | 6,521,000 | 9,454,000 | -11,829,000 | 4,294,000 | 6,578,000 | 3,060,000 | 4,951,000 | 6,148,564 | 5,616,737 | 1,440,407 | |
| Investing Activities | |||||||||||||||
| capital expenditure | -461,605 | ||||||||||||||
| Change in Investments | 4,023,000 | ||||||||||||||
| cash flow from investments | -461,605 | ||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 43,469,000 | -5,000 | -23,000 | -342,000 | 365,079 | 4,921 | |||||||||
| Other Short Term Loans | -20,467,000 | 4,853,000 | 15,510,000 | -11,697,000 | -1,873,000 | -4,987,000 | 9,154,000 | 2,038,000 | 1,656,000 | 5,829,000 | |||||
| Long term loans | -58,664,000 | 11,300,000 | 24,854,000 | -5,210,000 | 23,248,000 | 3,864,000 | -602,000 | -13,254,000 | 3,576,000 | 10,888,000 | |||||
| Hire Purchase and Lease Commitments | 2,065,000 | 9,748,000 | 6,825,000 | 1,528,000 | 14,945,000 | 3,092,000 | -27,000 | -10,283,000 | -173,000 | 3,655,000 | 3,191,000 | -1,151,000 | 1,431,889 | 1,170,501 | 2,712,610 |
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -3,559,000 | -8,723,000 | -1,055,000 | -717,000 | -963,000 | -564,000 | -318,000 | -241,000 | -541,000 | -548,000 | -613,000 | -430,000 | -343,000 | -204,941 | -185,725 |
| cash flow from financing | -33,329,000 | 17,637,000 | 46,474,000 | -12,914,000 | 37,627,000 | 2,600,000 | 10,530,000 | -35,089,000 | 4,456,000 | 15,997,000 | 2,555,000 | -1,923,000 | 1,453,945 | 970,481 | 4,361,299 |
| cash and cash equivalents | |||||||||||||||
| cash | -1,054,000 | 3,331,000 | -5,788,000 | -2,297,000 | 5,981,000 | 2,032,000 | -3,420,000 | 1,419,000 | 1,460,000 | 663,000 | -530,000 | 531,000 | 6,099 | -25,502 | 30,403 |
| overdraft | -295,000 | 295,000 | -327,000 | 8,884 | -1,737,905 | 2,056,021 | |||||||||
| change in cash | -1,054,000 | 3,331,000 | -5,788,000 | -2,297,000 | 5,981,000 | 2,032,000 | -3,420,000 | 1,419,000 | 1,460,000 | 958,000 | -825,000 | 858,000 | -2,785 | 1,712,403 | -2,025,618 |
navigator tissue uk limited Credit Report and Business Information
Navigator Tissue Uk Limited Competitor Analysis
Perform a competitor analysis for navigator tissue uk limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mega companies, companies in BB1 area or any other competitors across 12 key performance metrics.
navigator tissue uk limited Ownership
NAVIGATOR TISSUE UK LIMITED group structure
Navigator Tissue Uk Limited has no subsidiary companies.
Ultimate parent company
2 parents
NAVIGATOR TISSUE UK LIMITED
03639930
navigator tissue uk limited directors
Navigator Tissue Uk Limited currently has 9 directors. The longest serving directors include Mr Graham Cox (Jul 2019) and Ashley Miller (May 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Graham Cox | 57 years | Jul 2019 | - | Director | |
| Ashley Miller | 52 years | May 2024 | - | Director | |
| Mr Jose Carreira De Araujo | 60 years | May 2024 | - | Director | |
| Mr Antonio Soares | 51 years | May 2024 | - | Director | |
| Mr Antonio Redondo | 60 years | May 2024 | - | Director | |
| Dorival Martins De Almeida | 59 years | May 2024 | - | Director | |
| Mr Joao Le | 61 years | May 2024 | - | Director | |
| Mr Nuno Santos | 54 years | May 2024 | - | Director | |
| Vasco Ferreira | 56 years | May 2024 | - | Director |
P&L
April 2024turnover
186.8m
-29%
operating profit
5.5m
+50%
gross margin
26.9%
+91.94%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
8.5m
+2.8%
total assets
145.1m
+0.04%
cash
2.3m
-0.31%
net assets
Total assets minus all liabilities
navigator tissue uk limited company details
company number
03639930
Type
Private limited with Share Capital
industry
17220 - Manufacture of household and sanitary goods and of toilet requisites
17120 - Manufacture of paper and paperboard
incorporation date
September 1998
age
27
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
April 2024
previous names
accrol papers limited (July 2024)
accountant
-
auditor
COOPER PARRY GROUP LIMITED
address
delta building roman road, blackburn, BB1 2LD
Bank
HSBC BANK PLC
Legal Advisor
-
navigator tissue uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 21 charges/mortgages relating to navigator tissue uk limited. Currently there are 6 open charges and 15 have been satisfied in the past.
navigator tissue uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NAVIGATOR TISSUE UK LIMITED. This can take several minutes, an email will notify you when this has completed.
navigator tissue uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
